Bufo Alvarius & 5-MeO-DMT

The Sonoran Desert toad, Incilius alvarius (formerly Bufo alvarius), is native to the Sonoran Desert of the southwestern United States and northwestern Mexico. Glands on its skin secrete a milky defensive substance that contains 5-MeO-DMT, a powerful psychedelic compound. It is the only animal known to produce a psychedelic compound from its own body.

5-MeO-DMT is not the same as DMT (the better-known compound in Ayahuasca) and not the same as psilocybin in mushrooms. It acts strongly on serotonin receptors, comes on within seconds when vaporized, and the main experience is typically very short, often well under an hour, which is radically different from an evening-long Ayahuasca ceremony.

5-MeO-DMT also occurs in some South American plants and can be produced synthetically. This guide is educational: it does not provide instructions for obtaining, preparing or dosing anything, and a natural or ceremonial label does not establish safety or legality.

Demand for toad secretion has brought poaching, stressful capture and ‘milking,’ and displacement of wild toads, on top of habitat loss, road deaths, invasive predators, climate shifts and the deadly chytrid fungus. Buyers in an unregulated market cannot verify where secretion came from or how the animals were treated.

Conservation researchers and ethicists increasingly ask people to choose synthetic 5-MeO-DMT rather than wild toad secretion, so that demand stops pressuring a vulnerable species. Protecting the toad is part of honoring the medicine.

If you encounter any Bufo offering, ask where the medicine comes from, how the toads are treated, and whether a synthetic alternative is available. A provider who cannot answer these questions is asking for trust they have not earned.

In a 2019 naturalistic study of 42 people who inhaled vapor from dried toad secretion, ratings of life satisfaction and mindfulness increased and ratings of depression, anxiety and stress decreased, with some changes still present at a four-week follow-up. A Johns Hopkins survey of 362 adults found about 80 percent reported improvements in depression and anxiety after ceremonial 5-MeO-DMT use.

These studies are observational: they had no control groups, relied on self-report, and cannot prove the substance caused the improvements. A 2022 review of the clinical pharmacology of 5-MeO-DMT notes that only one clinical trial had been published, demonstrating the safety of vaporized doses up to 18 mg, and that much remains unknown.

Research interest is not proof. A controlled study with screening and medical oversight is not equivalent to a ceremony anywhere else, and no study establishes that 5-MeO-DMT cures trauma, depression or any other condition.